USD 5.87
(-11.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -17.76 Million USD | 23.3% |
2022 | -22.32 Million USD | -3.9% |
2021 | -19.66 Million USD | 7.58% |
2020 | -24.18 Million USD | 43.41% |
2019 | -43.98 Million USD | 21.8% |
2018 | -54.48 Million USD | -110.93% |
2017 | -28.87 Million USD | -70.61% |
2016 | -14.95 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -3.62 Million USD | 0.68% |
2024 Q2 | -2.36 Million USD | 34.39% |
2023 Q1 | -6.07 Million USD | -2.67% |
2023 Q4 | -3.46 Million USD | 9.78% |
2023 FY | - USD | 23.3% |
2023 Q3 | -3.83 Million USD | 17.81% |
2023 Q2 | -4.66 Million USD | 23.19% |
2022 Q1 | -5.47 Million USD | 9.07% |
2022 FY | - USD | -3.9% |
2022 Q4 | -5.91 Million USD | -9.51% |
2022 Q3 | -5.4 Million USD | 4.86% |
2022 Q2 | -5.67 Million USD | -3.73% |
2021 Q3 | -3.88 Million USD | 40.42% |
2021 Q4 | -6.02 Million USD | -54.78% |
2021 FY | - USD | 7.58% |
2021 Q1 | -5.28 Million USD | 16.37% |
2021 Q2 | -6.52 Million USD | -23.47% |
2020 Q4 | -6.32 Million USD | -43.92% |
2020 Q1 | -7.28 Million USD | 15.37% |
2020 FY | - USD | 43.41% |
2020 Q2 | -5.62 Million USD | 22.72% |
2020 Q3 | -4.39 Million USD | 21.93% |
2019 Q2 | -10.68 Million USD | 24.71% |
2019 FY | - USD | 21.8% |
2019 Q1 | -14.18 Million USD | 7.35% |
2019 Q3 | -9.18 Million USD | 13.99% |
2019 Q4 | -8.6 Million USD | 6.31% |
2018 Q3 | -13.18 Million USD | 25.88% |
2018 FY | - USD | -110.93% |
2018 Q4 | -15.31 Million USD | -16.16% |
2018 Q1 | -9.19 Million USD | -24.18% |
2018 Q2 | -17.78 Million USD | -93.48% |
2017 Q1 | -4.73 Million USD | 0.0% |
2017 Q2 | -7.42 Million USD | -56.75% |
2017 Q3 | -5.95 Million USD | 19.7% |
2017 Q4 | -7.4 Million USD | -24.18% |
2017 FY | - USD | -70.61% |
2016 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acutus Medical, Inc. | -13.48 Million USD | -31.682% |
Cerus Corporation | -26.53 Million USD | 33.072% |
OrthoPediatrics Corp. | -8.38 Million USD | -111.908% |
PetVivo Holdings, Inc. | -10.49 Million USD | -69.232% |
Talis Biomedical Corporation | -66.04 Million USD | 73.109% |
Vivos Therapeutics, Inc. | -16.67 Million USD | -6.507% |
Inogen, Inc. | -45.67 Million USD | 61.12% |
Spectral AI, Inc. | -12.26 Million USD | -44.838% |
Nano-X Imaging Ltd. | -47.69 Million USD | 62.762% |
CVRx, Inc. | -38.73 Million USD | 54.145% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -403.401% |
Helius Medical Technologies, Inc. | -12.1 Million USD | -46.692% |
Orthofix Medical Inc. | -86.98 Million USD | 79.583% |
Venus Concept Inc. | -26.11 Million USD | 31.988% |
Accelerate Diagnostics, Inc. | -49.77 Million USD | 64.317% |
Bioventus Inc. | -23.07 Million USD | 23.017% |
BrainsWay Ltd. | -2.31 Million USD | -668.498% |
Envoy Medical, Inc. | -18.23 Million USD | 2.621% |
IceCure Medical Ltd | -15.25 Million USD | -16.436% |
Lucid Diagnostics Inc. | -49.75 Million USD | 64.302% |
Monogram Orthopaedics, Inc. | -16.85 Million USD | -5.365% |
MaxCyte, Inc. | -44.12 Million USD | 59.753% |
NeuroOne Medical Technologies Corporation | -11.75 Million USD | -51.072% |
Nexalin Technology, Inc. | -5.69 Million USD | -212.015% |
PAVmed Inc | -75.74 Million USD | 76.552% |
Rapid Micro Biosystems, Inc. | -53.75 Million USD | 66.963% |
RxSight, Inc. | -41.03 Million USD | 56.722% |
Sight Sciences, Inc. | -49.41 Million USD | 64.059% |
SI-BONE, Inc. | -34.44 Million USD | 48.441% |
TELA Bio, Inc. | -40.63 Million USD | 56.292% |
TriSalus Life Sciences, Inc. | -58.29 Million USD | 69.536% |
Treace Medical Concepts, Inc. | -39 Million USD | 54.471% |
LivaNova PLC | 39.01 Million USD | 145.52% |
908 Devices Inc. | -34.02 Million USD | 47.803% |
Alphatec Holdings, Inc. | -110.59 Million USD | 83.941% |
Nemaura Medical Inc. | -7.28 Million USD | -143.72% |
NeuroPace, Inc. | -22.83 Million USD | 22.221% |
LENSAR, Inc. | -8.71 Million USD | -103.81% |
Apyx Medical Corporation | -18.11 Million USD | 1.943% |
Cutera, Inc. | -136.56 Million USD | 86.995% |
STRATA Skin Sciences, Inc. | -3.38 Million USD | -425.444% |
BioSig Technologies, Inc. | -28.15 Million USD | 36.912% |
Anika Therapeutics, Inc. | 2.51 Million USD | 805.882% |
ClearPoint Neuro, Inc. | -20.98 Million USD | 15.384% |
Integra LifeSciences Holdings Corporation | 383.56 Million USD | 104.63% |
Axonics, Inc. | 7.77 Million USD | 328.424% |
Outset Medical, Inc. | -153.78 Million USD | 88.452% |
IRIDEX Corporation | -7.44 Million USD | -138.453% |
PROCEPT BioRobotics Corporation | -98.09 Million USD | 81.895% |
IRadimed Corporation | 20.8 Million USD | 185.382% |
Tivic Health Systems, Inc. | -8.06 Million USD | -120.293% |
INVO Bioscience, Inc. | -6.88 Million USD | -158.139% |
Telesis Bio, Inc. | -40.49 Million USD | 56.141% |
Viemed Healthcare, Inc. | 36.67 Million USD | 148.423% |
Varex Imaging Corporation | 67.2 Million USD | 126.429% |
Quipt Home Medical Corp. | 44.07 Million USD | 140.299% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -63.385% |
Pulmonx Corporation | -55.09 Million USD | 67.763% |
Dynatronics Corporation | -976 Thousand USD | -1719.657% |
Modular Medical, Inc. | -17.1 Million USD | -3.841% |
ReShape Lifesciences Inc. | -14.48 Million USD | -22.61% |
Semler Scientific, Inc. | 23.58 Million USD | 175.289% |
InMode Ltd. | 196.28 Million USD | 109.048% |
Bruker Corporation | 599 Million USD | 102.965% |
Cytosorbents Corporation | -28.81 Million USD | 38.356% |
DexCom, Inc. | 916.7 Million USD | 101.937% |
Align Technology, Inc. | 799.03 Million USD | 102.223% |
Viveve Medical, Inc. | -20.61 Million USD | 13.857% |
ZimVie Inc. | 91.07 Million USD | 119.501% |
Movano Inc. | -29.12 Million USD | 39.021% |
Cytek Biosciences, Inc. | -4.4 Million USD | -302.904% |
Nexalin Technology, Inc. | -5.69 Million USD | -212.015% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -403.401% |
Tandem Diabetes Care, Inc. | -194.65 Million USD | 90.876% |
Profound Medical Corp. | -27.12 Million USD | 34.522% |
Insulet Corporation | 323.6 Million USD | 105.488% |
enVVeno Medical Corporation | -25.01 Million USD | 29.011% |
Surmodics, Inc. | 1.18 Million USD | 1594.949% |
iCAD, Inc. | -6.56 Million USD | -170.526% |
Nuwellis, Inc. | -16.35 Million USD | -8.584% |
Biotricity, Inc. | -8.82 Million USD | -101.172% |
iRhythm Technologies, Inc. | -96.86 Million USD | 81.665% |
Aethlon Medical, Inc. | -11.84 Million USD | -49.885% |
InspireMD, Inc. | -20.91 Million USD | 15.069% |
PAVmed Inc. | -75.74 Million USD | 76.552% |
BIOLASE, Inc. | -15.13 Million USD | -17.313% |
Beyond Air, Inc. | -59.03 Million USD | 69.914% |
FONAR Corporation | 28.25 Million USD | 162.864% |
AxoGen, Inc. | -13.32 Million USD | -33.253% |
Vivani Medical, Inc. | -26.6 Million USD | 33.253% |
Tactile Systems Technology, Inc. | 24.54 Million USD | 172.369% |
Inari Medical, Inc. | 7.11 Million USD | 349.684% |
UFP Technologies, Inc. | 72.74 Million USD | 124.415% |
QT Imaging Holdings, Inc. | -3.38 Million USD | -424.546% |
Heart Test Laboratories, Inc. | -6.15 Million USD | -188.499% |
Tenon Medical, Inc. | -15.52 Million USD | -14.374% |
Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -16.337% |
Co-Diagnostics, Inc. | -41.47 Million USD | 57.18% |
AdaptHealth Corp. | -171.09 Million USD | 89.62% |
Sintx Technologies, Inc. | -6.6 Million USD | -169.091% |
NanoVibronix, Inc. | -3.43 Million USD | -417.031% |
Quanterix Corporation | -38.08 Million USD | 53.371% |
Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -63.385% |
Sensus Healthcare, Inc. | 30 Thousand USD | 59300.0% |
Pacific Biosciences of California, Inc. | -277.28 Million USD | 93.595% |
TransMedics Group, Inc. | -7.6 Million USD | -133.592% |
ReWalk Robotics Ltd. | -21.76 Million USD | 18.401% |
NeuroMetrix, Inc. | -7.09 Million USD | -150.289% |
Hyperfine, Inc. | -47.06 Million USD | 62.262% |
Establishment Labs Holdings Inc. | -58.3 Million USD | 69.541% |
Biomerica, Inc. | -5.99 Million USD | -196.346% |
Bone Biologics Corporation | 479.57 Thousand USD | 3803.302% |
AVITA Medical, Inc. | -39.56 Million USD | 55.115% |
Bluejay Diagnostics, Inc. | -9.17 Million USD | -93.613% |
Silk Road Medical, Inc | -45.08 Million USD | 60.603% |